ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$1.39
-0.01 (-0.71%)
As of Aug 9, 10:58 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,243.9% upside
Low Target $17.80
Average Target $32.58
High Target $40.39
Current Price $1.39
Current
$1.39
Target
$32.58
$17.80 $32.58 avg $40.39
Scenario Analysis
Bear Case
$17.80
1,180.6%
Low target
Base Case
$32.58
+2,243.9%
Avg target
Bull Case
$40.39
+2,805.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$2.35
-40.9% from high
52-Week Low
$0.77
+80.8% from low
Target vs 52W High
$32.58
+1,286.4% vs high
Next Earnings Report
Aug 15, 2026
Today
EPS Est: $-0.26
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.2%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.8%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.8%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.8%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.6%